Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$233.45 - $247.73 $10,505 - $11,147
45 New
45 $11.2 Million
Q2 2022

Jan 17, 2024

SELL
$234.74 - $275.42 $12 Million - $14.1 Million
-51,080 Closed
0 $0
Q1 2022

Jan 17, 2024

SELL
$243.64 - $270.48 $27.4 Million - $30.4 Million
-112,553 Reduced 68.78%
51,080 $13.6 Billion
Q4 2021

Jan 17, 2024

BUY
$230.08 - $250.94 $834,500 - $910,159
3,627 Added 2.27%
163,633 $41.2 Billion
Q3 2021

Jan 17, 2024

SELL
$232.72 - $256.47 $6.47 Million - $7.13 Million
-27,785 Reduced 14.8%
160,006 $39.3 Billion
Q2 2021

Jan 17, 2024

BUY
$232.65 - $254.58 $1.46 Million - $1.6 Million
6,294 Added 3.47%
187,791 $45.7 Billion
Q1 2021

Jan 17, 2024

BUY
$232.09 - $256.88 $143,199 - $158,494
617 Added 0.34%
181,497 $44.1 Billion
Q4 2020

Jan 17, 2024

SELL
$221.92 - $245.94 $86,326 - $95,670
-389 Reduced 0.21%
180,880 $45.3 Billion
Q3 2020

Jan 17, 2024

BUY
$215.77 - $276.76 $27.9 Million - $35.8 Million
129,270 Added 248.6%
181,269 $42.2 Billion
Q2 2020

Jan 17, 2024

SELL
$219.9 - $263.41 $147,333 - $176,484
-670 Reduced 1.27%
51,999 $12.4 Billion
Q1 2020

Jan 17, 2024

SELL
$195.69 - $279.01 $22,895 - $32,644
-117 Reduced 0.22%
52,669 $12.1 Billion
Q4 2019

Jan 17, 2024

BUY
$236.45 - $266.82 $168,352 - $189,975
712 Added 1.37%
52,786 $14.4 Billion
Q3 2019

Jan 17, 2024

SELL
$230.58 - $256.08 $50,727 - $56,337
-220 Reduced 0.42%
52,074 $13.2 Billion
Q2 2019

Jan 17, 2024

BUY
$217.4 - $246.08 $2.99 Million - $3.39 Million
13,773 Added 35.75%
52,294 $13.2 Billion
Q1 2019

Jan 17, 2024

BUY
$206.05 - $248.17 $2.51 Million - $3.02 Million
12,175 Added 46.21%
38,521 $9.62 Billion
Q4 2018

Jan 17, 2024

SELL
$204.73 - $257.93 $5,118 - $6,448
-25 Reduced 0.09%
26,346 $5.94 Billion
Q3 2018

Jan 17, 2024

BUY
$233.07 - $256.0 $29,599 - $32,512
127 Added 0.48%
26,371 $6.88 Billion
Q2 2018

Jan 17, 2024

BUY
$208.1 - $233.85 $12,486 - $14,031
60 Added 0.23%
26,244 $6.29 Billion
Q1 2018

Jan 17, 2024

BUY
$205.46 - $240.27 $2.67 Million - $3.12 Million
12,977 Added 98.26%
26,184 $5.67 Billion
Q4 2017

Jan 17, 2024

SELL
$189.0 - $222.64 $41,391 - $48,758
-219 Reduced 1.63%
13,207 $2.83 Billion
Q3 2017

Jan 17, 2024

BUY
$186.89 - $198.9 $13,269 - $14,121
71 Added 0.53%
13,426 $2.63 Billion
Q2 2017

Jan 17, 2024

BUY
N/A
253 Added 1.93%
13,355 $2.61 Billion
Q1 2017

Jan 17, 2024

BUY
N/A
613 Added 4.91%
13,102 $2.4 Billion
Q4 2016

Jan 17, 2024

BUY
N/A
12,489
12,489 $2.07 Billion

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Dixon Mitchell Investment Counsel Inc. Portfolio

Follow Dixon Mitchell Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Mitchell Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dixon Mitchell Investment Counsel Inc. with notifications on news.